You are leaving a Neuronetics website. This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.
Click here to continue.
NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. NeuroStar TMS Therapy non-invasively stimulates the left prefrontal cortex of the brain to treat the symptoms of major depression. It requires 4 to 6 weeks of treatment. To return to the Neuronetics website for full safety and prescribing information, Click here.